Health

Co-Diagnostics outlines clinical trial timeline and targets mid-2026 commercialization for PCR platform

Earnings Call Insights: Co-Diagnostics, Inc. (CODX) Q2 2025 Management View CEO Dwight H. Egan reported continued progress on the Co-DX PCR point-of-care platform, stating, “We remain on track to initiate clinical evaluations for all tests in our pipeline during 2025.” Egan highlighted imminent clinical evaluations for the COVID-19 test and noted additional pipeline tests including […]
  • maskobus
  • Aug 16, 2025